Circio Holding is a Norwegian biotechnology company developing circular RNA expression technology for gene and cell therapy. Its proprietary circVec platform is designed to produce multifunctional circular RNA inside target cells as a next-generation approach versus conventional linear RNA constructs. The business is research- and platform-driven, with activities focused on advancing the technology rather than commercial product sales. It operates in the early-stage biopharma segment serving potential partners in genetic medicine and advanced therapeutics.
| Year | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| 2022 | 10 | — | -432.9 | — |
| 2023 | 0.1 | -98.8% | -112.9 | — |
| 2024 | 0 | -100% | 57.5 | — |
| 2025 | 0 | — | -45.9 | -179.8% |
All markets — KeepWinning global stock screener
Other companies on Oslo: Cambi ASA (CAMBI), Andfjord Salmon Group AS (ANDF), ShaMaran Petroleum Ltd. (SNM), Rogaland Sparebank (ROGS), Grieg Seafood ASA (GSF), Ventura Offshore Holding Ltd. (VTURA)